NCT07138781View on ClinicalTrials.gov

Ketamine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 23, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2026

Conditions
KetamineAdjuvantExternal Oblique Intercostal Plane BlockThoracotomyPain
Interventions
DRUG

Ketamine

Patients will receive 29 ml bupivacaine 0.25% + 1 ml ketamine (50 mg).

DRUG

29 ml bupivacaine 0.25% + 1 ml saline

Patients will receive 29 ml of bupivacaine 0.25% + 1 ml of saline.

Trial Locations (1)

31527

RECRUITING

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT07138781 - Ketamine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain | Biotech Hunter | Biotech Hunter